Trastuzumab and Pertuzumab Without Chemotherapy in Early-Stage Her2+Breast Cancer: a Plain Language Summary of the Phergain Study

AuthID
 P-00X-FFH
14
Author(s)
Perez-Garcia, JM
·
Gebhart, G
·
Borrego, MR
·
Dalenc, F
·
Kerrou, K
·
Colleoni, M
·
Braga, S
·
Malfettone, A
·
Sampayo-Cordero, M
·
Cortes, J
·
Llombart-Cussac, A
Document Type
Article in Press
Year published
2022
Published
in FUTURE ONCOLOGY, ISSN: 1479-6694
Indexing
Wos®
Pubmed®
Google Scholar®
Publication Identifiers
Pubmed: 36300423
Wos: WOS:000873668000001
Source Identifiers
ISSN: 1479-6694
Export Publication Metadata
Marked List
 Add to Marked List
Citations
Oops! It looks like you don't have access to this content.

This section is restricted to uses with b-on access.

CORE Conference
No information about CORE Rank

During the preprocessing phase, only publications of type 'Proceedings Paper' or 'Proceedings' are automatically processed to identify their CORE Rank.

TIP: If your publication's CORE Rank is missing, you can contact with your institutional manager to have the correct ranking manually added to the record.

Journal Factors
Oops! It looks like you don't have access to this content.

This section is restricted to uses with b-on access.

Info
At this moment we don't have any links to full text documens.

footer slogan

Useful Links

Get Help

© 2026 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service